CurrentArizona Complete HealthPolicy CP.MP.82

NICU Apnea Bradycardia Guidelines

Clinical criteria governing readiness for discharge of neonates with apnea, bradycardia, or desaturation events and guidance for continued inpatient stay, home monitoring, and caffeine therapy considerations for infants in Arizona Complete Health plans.

Policy Summary

PayerArizona Complete Health

PolicyNICU Apnea Bradycardia Guidelines

Policy CodePolicy CP.MP.82

Change TypeMaterial revisions and clarifications

Effective Date

Next Review Date

Key ActionEnsure infants meet discharge readiness criteria including 5-7 spell-free days, ≥7 days off caffeine, and documented caregiver proficiency if discharged with a home monitor.

SourceLink

POLICY UPDATE CHANGES

Changed requirement for no clinically significant events before discharge from '5' to '5-7' days.

Updated oxygen desaturation threshold language from < 85% to ≤ 85% for clinically significant events.

Added caregiver agreement, demonstrated monitor management, and home assessment requirements for discharge when home cardiorespiratory monitoring will be used.

5-7 daysspell-free observation prior to discharge

≥20sapnea definition duration

≤85%oxygen desaturation threshold

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria — Discharge Readiness and Continued Observation

Discharge readiness (Initial criteria)

Covered when ALL of the following are met for discharge from inpatient care for significant cardiorespiratory events:

I.A: Infant demonstrates maturity of respiratory control and meets one of the subconditions 1, 2, or 3 below

Top-level requirement

I.A.1-3

I.A.1
- I.A.1.a-e: a. No apnea >= 20 seconds; b. No apnea <20 sec with bradycardia <80 bpm; c. No apnea <20 sec with valid, prolonged or frequent oxygen desaturations <=85% (excludes transient desats unless requiring supplemental oxygen); d. No isolated bradycardia <80 bpm unrelated to feedings; e. No events requiring stimulation, artificial ventilation (bagging or intubation), or supplemental oxygen to restore normal breathing, heart rate, and oxygenation
  Detailed event definitions per policy
I.A.2: If significant events continue to near-term or longer, all of the following must be met: a. Evaluation excludes other causes and events appear associated with gastro-esophageal reflux; b. Appropriate anti-reflux measures resolve or significantly reduce severity/duration of events (note: five days of observation may not be required)
Allows clinical judgement when reflux is implicated
I.A.3: Infant has non-clinically significant, self-limited apnea spells and all of the following: a. Does not require stimulation to resume breathing; b. Will be discharged to home with a cardiorespiratory monitor; c. No clinically significant cardiorespiratory event for five to seven days prior to discharge; d. Parents/caregivers agree with plan and have demonstrated proficiency in monitor management, stimulation, and completed infant CPR training; e. Home situation assessed and deemed adequate
Criteria when home monitoring is planned

I.B: If nasal cannula airflow is used to address events, infant should be free of clinically significant events for five to seven days on the same level of support planned for discharge5-7 days

Maintain observation on planned discharge support level

I.C: Infant has not received caffeine citrate for at least seven days prior to planned discharge>=7 days off caffeine

Minimum caffeine-free interval before discharge

I.D: Infant has no additional condition(s) requiring inpatient care

No other inpatient care indications present

Episodes that occur in association with oral feedings are common in premature infants because of incoordination of sucking, swallowing, and breathing; these feeding-associated events should be evaluated on an individualized basis considering the severity of bradycardia, degree of desaturation, and the interventions required. The policy specifically notes that bradycardia associated with feeding that resolves with interruption of feeding is generally not a reason to delay discharge, and that parental instruction on identifying and correcting feeding problems is recommended.

Continued inpatient observation may be required when the infant does not meet the specified discharge criteria. Triggers for ongoing inpatient care include any clinically significant cardiorespiratory events during the observation window (see I.A.1), need for respiratory stimulation, bag-mask ventilation or intubation, or requirement for supplemental oxygen to restore normal status. Additionally, if nasal cannula flow is being used to manage events, the infant should be free of clinically significant events for five to seven days on the same level of support planned for discharge. Infants who have received caffeine citrate must be off caffeine for at least seven days prior to planned discharge, and any other inpatient-care conditions also justify continued hospitalization.

Coding, Key Clinical Thresholds, and Operational Metrics

No billing codes specifiedmixed

No codes listed

inv-05: Spell-free observation prior to discharge (operational metric)

Spell-free observation prior to dischargeNo clinically significant cardiorespiratory events for five to seven days prior to discharge (5-7 days).

Components required during observationAbsence of apnea ≥20 seconds, apnea <20 seconds with bradycardia <80 bpm, apnea <20 seconds with valid/prolonged/frequent desaturations ≤85%, isolated bradycardia <80 bpm unrelated to feedings, and no events requiring stimulation, artificial ventilation, or supplemental oxygen.

Same level of support ruleIf nasal cannula airflow is used, infant should be free of clinically significant events for 5-7 days on the same level of support planned for discharge.

inv-06: Apnea duration threshold

Apnea duration thresholdApnea defined as cessation of breathing lasting at least 20 seconds (≥ 20 seconds).

Provider Actions, Documentation, and Treatment Guidance

Documentation Required

Required discharge documentation when sending infant home with monitor

When an infant is discharged to home with a cardiorespiratory monitor, the following documentation must be completed and included in the medical record prior to discharge. This documentation verifies caregiver training, home safety assessment, device instructions, and clinical rationale for home monitoring.

Caregiver agreement with the plan of care and documented demonstration of proficiency in managing the cardiorespiratory monitor (including replacing sensors/electrodes and troubleshooting common alarms).
Documented completion of infant cardiopulmonary resuscitation (CPR) training by parents/caregivers prior to discharge. Attendance and completion of an approved infant CPR course must be noted.
Documentation that parents/caregivers have demonstrated proficiency in providing stimulation techniques to resolve brief apnea/bradycardia events as applicable.
A home situation assessment documented as adequate for safe monitoring (includes home environment, availability of responsible caregiver(s), access to telephone/transport, and any social determinants that could affect safe care).
Clear written and verbal instructions provided to caregivers on monitor use, alarm significance, when to seek emergency care, routine follow-up schedule, and contact information for questions or device issues. Documentation must note that instructions were provided and understood.
Clinical rationale for home monitoring clearly stated, including the type of cardiorespiratory events observed, stability period prior to discharge (e.g., no clinically significant events for five to seven days where applicable), and expected duration of home monitoring.

Key Definitions

inv-14: Definition of a clinically significant cardiorespiratory event with multiple component criteria

Primary definitionClinically significant cardiorespiratory event: apnea ≥20 seconds; or apnea <20 seconds accompanied by bradycardia <80 beats per minute; or apnea <20 seconds with valid, prolonged, or frequent oxygen desaturations ≤85%.

Isolated bradycardiaAn isolated bradycardia <80 beats per minute (unrelated to feedings) is considered clinically significant.

Severity criteriaAny event requiring stimulation, artificial ventilation (bagging or intubation), or supplemental oxygen support to restore normal breathing, heart rate, or oxygenation is clinically significant.

inv-15: Apnea of prematurity definition

Apnea of prematurity - duration-based definitionCessation of breathing that lasts for at least 20 seconds (≥ 20 seconds).

Alternate criteria for shorter events

Background and Clinical Context

Apnea of prematurity is a common condition in preterm infants and is often closely associated with bradycardia; it contributes substantially to prolonged NICU stays and parental anxiety. The Committee on Fetus and Newborn defines apnea of prematurity as a cessation of breathing lasting at least 20 seconds or a shorter pause accompanied by bradycardia, cyanosis, or pallor in an infant < 37 weeks' gestational age. Most infants outgrow these events by 37 weeks post-conceptional age, although those born extremely preterm may have apnea persisting to later post-conceptional ages. Caffeine citrate is the recommended pharmacologic treatment, noting its relatively long half-life in preterm infants.